Home The Center Research Positions Seminars and Courses Events and News Links Contact us
Abstracts
April 23

Håkan Widner: Shopping for the right cell to graft.
Introduction by Olle Lindvall

Cell based therapy for neurologicl disorders have the potential to become an important treatment alternative. The best example is in Parkinson's disease (PD), but cell transplantation in other disorders such as demyelinating conditions, stroke and Huntington's disease have already been attempted. The clinical effects limitations of of neural grafting in PD and other disorders will be briefly reviewed.
For neural repair to be successful, transplanted neurons so far have had to be embryonic and this has limited the application of neural tissue transplantation.
In vitro expansion of pleuropotent progenitors or other types of cells, and in vitro controlled differentiation to a defined cell population are being envisioned as future limitless cell sources. In the Parkinson's disease case, the envisioned cell type should be a dopamine producing neuron. However, from the clinicians point of view, there are more requirements prior to a cell to be transplantated and the fine print and detailed specification on the properties of the cell to be implanted will be outlined and discussed. Some aspects of the regulatory aspects for a commercial type of cell will also be discussed.

Refs: Widner H. Translantation of neuronal and non-neuronal cells into the brain. Chapter 11 in Immune and Inflammatory respones in the nervous system. NJ Rothwell Bios Scientific Publ, 2002
Brevig T, Holgersson J, Widner H. Xenotransplantation for CNS repair: immunological barriers and strategies to overcome them. Trends in Neuroscience, 23: 337-344, 2000.
Widner H. The case FOR embryonic neural tissue transplantation as a therapy for Parkinson's disease. Advances in Neurology; 80 641-650, 1999.

 

May 7

Markus Ringner: Analysing microarray data with
Application from cancer studies. Introduction by Carsten Petersson

As more and more data sets from high-throughput technologies become available, analysis methods that combine information from many sources will be very useful to extend the results obtainable from one data set. Strategies for analysing microarray data from several sources or platforms will be presented. The methods will be illustrated with applications for investigating i) the impact of gene copy number changes on gene expression, and ii) if one can link genes found to be relevant in a comprehensive study of hormone and growth signaling pathways in breast cancer to disease progression through previously published breast tumor expression studies.

 

May 14

Bengt Juliusson: Generaton of human neural progenitor cell lines. Inroduction by Anders Björklund

Cell based transplantation therapy has the potential to become an alternative treatment for Parkinson's disease. We are evaluating the possibility to use region specific immortalized human neural cell lines as a source of cells for such a therapy. The procedure for generating cell lines is described by the following five steps.
1) Establishment of primary cell cultures from fetal human ventral mesencephalon.
2) Transduction of cells with a retroviral vector containing v-myc as the immortalizing gene.
3) Expansion of cell lines and subcloning into clonal cell lines.
4) Characterization of cells to select cell lines with a dopaminergic phenotype.
5) Evaluation of the therapeutic potential of the cell lines after transplantation to animal models for Parkinson's disease. The generated cell lines can also serve as tools in gene expression studies to discover new therapeutic factors.

Review article: Martinez-Serrano A, Rubio FJ, Navarro B, Bueno C, Villa A Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. Curr Gene Ther 2001 Sep;1(3):279-99

 

May 21

Mikael Sigvardsson: Molecular mechanisms in adipocyte differentiation. Introduction by Stefan Karlsson

Adipocyte progenitors develop already in the early embryo and are of key importance for the metabolic homeostasis in both humans and mice. The molecular mechanisms that stimulate the development of these cells from mesenchymal stem cells and fibroblastic cells has been under detailed investigation using in vitro differentiation systems. This work has resulted in the identification of a number of transcription factors with important roles this process. Among these are the PPARgs as well as the C/EBP proteins a, b and d. Two other proteins that are suggested to play roles in adipogenesis are the helix-loop-helix proteins ADD1/SREBP and EBF-1/OE-1. EBF is expressed at the earliest stages of differentiation but in contrast to the C/EBP b and d proteins, who themselves are rather poor stimulators of terminal adipogenisis in vitro, EBF-1 is able to induce the adipogenic program in fibroblasts with a kinetic and efficiency comparable to that of PPARg2. Ectopic expression of EBF-1 induced adipocyte differentiation of NIH 3T3 fibroblasts and was also able to enhance adipogenesis in 3T3-L1 cells as well as in mouse embryonic fibroblasts. To gain a deeper insight into the molecular mechanisms involved in adipogenesis, we analysed the differences in mRNA levels, in NIH 3T3 infected either with an empty retrovirus or cells infected with viruses harbouring PPARg2 or EBF-1 cDNA, using Affymetrix DNA microarrays. Cell culture RNA was harvested and analyzed 5-6 days after retroviral infection, before addition of hormonal stimulators of adipogenesis, and at several time points after hormonal induction of differentiation. The initial expression profiles obtained differed between EBF-1 and PPARg2 induced adipogenesis and the similarities in RNA expression did not become apparent until day 4 after induction of differentiation by the addition of external stimuli. At this time, not only the transcription factor induced, but also the vector transduced control cells expressed significant amounts of fat cell related genes. However, while the expressing of these marker genes were further increased in the EBF or PPARg at day 10 after stimulation, their expression declined in the vector transduced cells suggesting that commitment to adipogenic cell fate occurred after a global activation of adipocyte related genes. The initial differential gene expression pattern in the trancription factor transduced cells was also reflected in that EBF-1 transduced cells had the potential to differentiate into adipocytes in the absence of insulin, while this was necessary for significant amounts of PPARg induced adipogenesis. This discrepancy between EBF-1 and PPARg2 might be explained by the finding that EBF-1 appear to enhance the expression of insulin like growth factor 2 possibly by direct interaction with enhancer elements 3' of this gene. We do not know if the induction of IGFII transcription explain the differential requirement of external stimuli in the adipocyte differentiation pathways but the identification of the IGFII/H19 locus as a potential EBF-1 target gene provides a possible clue to novel functions of EBF proteins also in embryogenesis and tumorogenisis.

Recommended reading

Akerblad, P., Lind, U., Liberg, D., Bamberg, K., and Sigvardsson, M. (2002). Early B-cell Factor (O/E-1) is a promoter of adipogenisis and involved in control of genes important for terminal adipocyte differentiation. Mol Cell Biol 22, 8015-8025.
Cowherd, R. M., Lyle, R. E., and McGehee, R. E., Jr. (1999). Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 10, 3-10.

Rosen, E. D., Walkey, C. J., Puigserver, P., and Spiegelman, B. M. (2000). Transcriptional regulation of adipogenesis. Genes Dev 14, 1293-1307.

 

May 28

Johan Staaf: Production of DNA microarrays for gene expression analysis.

Abstract
Gene expression profiling using microarrays in conjunction with the availability of complete genomic data for an increasing number of organisms has introduced a new paradigm in biomedical research. These achievements revolutionize biology, and offer a new means for solving problems within the life sciences. Array technology builds on classical hybridization chemistry. The novelty lies in the scale: currently, tens of thousands of gene fragments can be immobilized on single arrays, which allows the researcher a truly global view of the transcriptome in a single experiment

The biological complexity can be resolved by refining sample preparation. Instead of analyzing whole tissue biopsies, individual cell types can be isolated by laser capture micro-dissection, by fluorescence-activated cell sorting (FACS) or antibody coated magnetic beads, allowing only those cells showing a specific morphology or phenotype to be studied. This is a major advance, which is likely to rapidly become a required feature of advanced studies probing into the mechanistic analysis of cell and tissue differentiation. This increases the demands on sensitivity of the analytical methods, as well as on amplification methods to allow array technology to be applied starting from minimal amounts of RNA.

The Swegene DNA microarray resource center.
The technique had earlier been transferred from the National Human Genome Research Center at NIH to Dept Oncology and was moved and allowed to expand in new laboratory space at the BioMedical Center in conjunction to the Stem Cell Center in Lund, and is now up running in 2003. The aim of the centre is to provide south-west Swedish research groups access to state-of-the-art DNA microarray technology. This has been accomplished by establishing platforms and expertise for:

- Construction of high quality, high density microarray chips using different clone platforms.

- Design and construction of large scale PCR clone libraries through extensive automatisation involving liquid handling robots.

- Comprehensive RNA expression analysis in the most commonly used experimental systems (i.e. human, mouse and rat and eventually in fruit fly, zebra-fish, yeast and other species),

- High-density BAC arrays for comparative genomic hybridisation analysis of DNA copy gains and losses.

- Preparation of small sample amounts, RNA amplification (about to begin), labelling and
hybridisation.

- database handling and statistical analysis in cooperation with the bioinformatics center.

Recommended Reading:
Schulze A. , Downward J. Navigating gene expression using microarrays - a technology review. Nature Cell Biology, vol 3, August 2001.

 

June 4

Ewa Sitnicka: Receptor ligand interactions in the regulation of hematopoietic stem cell fate. Introduction by Sten Eirik Jacobsen

All blood cell lineages arise from common hematopoietic stem cells (HSC), which due to their capacity to self-renew maintain hematopoiesis throughout the lifespan of an individual. The enormous proliferative and differentiation potential of HSC can be illustrated by 3-5 million mature blood cells produced in man per second. The molecular mechanism regulating HSC fate decisions between self-renewal and lineage commitment remain poorly understood. However, evidence supports that blood lineage maturation and HSC self-renewal are regulated in part by hematopoietic cytokines interacting with their specific surface receptors.
Flt3 (or flk2) is a cytokine tyrosine kinase receptor primarily expressed at very early stages of hematopoiesis. Mice deficient in flt3 or flt3 ligand (FL) expression show deficient early B lymphopoiesis, but myeloid development is not affected. Although flt3 was cloned based on its expression in the HSC compartment, we demonstrated recently, that HSC in mouse bone marrow lack detectable cell surface flt3 expression (Adolfsson et al, Immunity 2001). To further address the role of flt3 and its ligand in early hematopoietic development we investigated hematopoiesis in FL-deficient mice, focusing the studies on the role of FL in regulation of HSC, common lymphoid progenitors (CLP) and common myeloid progenitors (CMP). Whereas HSC and common myeloid progenitors are unaffected, FL-deficient mice show striking reductions in CLP, suggesting a role for FL in early lymphoid development throughout the generation of CLP form HSC (Sitnicka et al, Immunity 2002). An indispensable role of flt3 signaling in B cell development was established through studies in mice double deficient in FL and Interleukin-7 (IL-7) receptor expression. Although both of these cytokines have been demonstrated to be important regulators of B cell development, normal levels of immunoglobulins are produced in mice deficient in FL or IL-7R expression. However, based on potent synergistic interactions between these two ligands in vitro we hypothesized that the concerted action of FL; acting at very early stages of lymphopoiesis and the lymphoid lineage specific factor IL-7 might be indispensable for B cell development in vivo. This hypothesis is supported by the finding that mice double deficient in FL and IL-7 receptor expression completely lack mature conventional IgM+ B cells, IgA+ plasma cells, B1 B cells and fail to produce immunoglobulins.

Recommended literature:
1. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-11. (2001).
2. Lyman, S. D. & Jacobsen, S. E. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91, 1101-34. (1998).
3. Fry, T. J. & Mackall, C. L. Interleukin-7: from bench to clinic. Blood 99, 3892-904. (2002).
4. Adolfsson, J. et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c- kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15, 659-69. (2001).
5. Sitnicka, E. et al. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17, 463-72. (2002).
6. Veiby, O. P., Lyman, S. D. & Jacobsen, S. E. Combined signaling through interleukin-7 receptors and flt3 but not c- kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood 88, 1256-65. (1996).

June 11

Florian Lueders: Slalom encodes a PAPS transporter essential for segment polarity and dorsal ventral axis determination in drosophilia. Introduction by Udo Haecker

Sulfation of all macromolecules entering the secretory pathway in higher organisms occurs in the Golgi and requires the high-energy sulfate donor adenosine 3'-phosphate 5'-phosphosulfate. Here we report the first molecular identification of a gene that encodes a transmembrane protein required to transport adenosine 3'-phosphate 5'-phosphosulfate from the cytosol into the Golgi lumen. Mutations in this gene, which we call slalom, display defects in Wg and Hh signaling, which are likely due to the lack of sulfation of glycosaminoglycans by the sulfotransferase sulfateless. Analysis of mosaic mutant ovaries shows that sll function is also essential for dorsal-ventral axis determination suggesting that sll transports the sulfate donor required for sulfotransferase activity of the dorsal-ventral determinant pipe.


Keywords: Hedgehog/Glycosaminoglycan/Pipe/Sulfation/Wingless

Introduction
Secreted signaling molecules of the FGF, Hh, TGFb and WNT families rely on proteoglycans (PGs) for efficient activation of their respective signaling pathways (reviewed in Perrimon and Bernfield, 2000). PGs consist of secreted or transmembrane core proteins to which glycosaminoglycan (GAG) side chains are attached at specific consensus sites. In Drosophila, the secreted PG Perlecan (Park et al., 2003), the transmembrane PG Syndecan (Spring et al., 1994), and two members of the Glypican-family of glycosylphosphatidylinositol (GPI)-anchored PGs have been identified. Phenotypes associated with loss of function mutations of the Glypican-encoding genes dally (Nakato et al., 1995) and dally-like (dlp) (Baeg et al., 2001; Khare and Baumgartner, 2000) have revealed the requirement of these PGs for efficient activation of several signal transduction pathways.
The function of PGs is critically dependent on the integrity of the attached GAGs. GAGs are unbranched polysaccharide chains, which are synthesized on proteoglycan core proteins in the Golgi and undergo complex modification reactions before the PG, that they are attached to, is transported to the cell surface. In the case of Glypican, heparan sulfate (HS) chains, which consist of a sugar backbone of alternating units of N-acetyl-glucosamine (GlcNAc) and glucuronic acid (GlcA) are synthesized on the core protein. The nucleotide sugar substrates for this reaction are synthesized in the cytoplasm and must be transported into the Golgi. In Drosophila, the activated precursor UDP-GlcA is synthesized from UDP-glucose by the enzymatic activity of the sugarless (sgl) (Binari et al., 1997; Häcker et al., 1997; Haerry et al., 1997) gene product, a homolog of mammalian UDP-glucose dehydrogenases. The gene product of fringe connection (frc), a predicted ER/Golgi multi-pass transmembrane protein has been shown to transport UDP-GlcA and UDP-GlcNAc from the cytosol into the Golgi (Goto et al., 2001; Selva et al., 2001). Mutations in either gene severely affect the Wg and FGF signaling pathways. Elongation of the HS chains requires the activity of HS polymerases. tout-velu (ttv), encodes a protein with homology to the mammalian HS co-polymerase EXT1and has been demonstrated to be required specifically for Hh signaling (Bellaiche et al., 1998). Subsequent to their synthesis, GAGs undergo multiple modifications such as epimerization and sulfation. Mutations in sulfateless (sfl), a homologue of vertebrate N-deacetylase/ N-sulfotransferases (NDST) lead to a severe reduction in the activity of the Wg, Hh and FGF signaling pathways (Lin et al., 1999; Lin and Perrimon, 1999). A characteristic feature of all mutations in genes involved in GAG biosynthesis is, that their segment polarity phenotypes can be rescued by ectopic expression of wg or hh, suggesting that GAGs are not essential components of the respective signaling cascades but accessory factors most likely required for the proper distribution of extracellular signaling molecules throughout morphogenetically active tissues in vivo.

GAGs have also been proposed to play a role in the determination of the dorsal-ventral (D/V) axis of the Drosophila embryo (Sen et al., 1998). The D/V polarity of the embryo is established during oogenesis by asymmetric expression of the key D/V determinant pipe (pip) in the follicle cell epithelium. pip expression in the ventral follicle cell layer is necessary and sufficient to trigger a serine-protease cascade in the perivitelline space, which leads to the generation of an active ligand for the transmembrane receptor Toll (Tl). Activation of Tl on the ventral side of the embryo results in a gradient of nuclear localization of the transcription factor Dorsal, which patterns the D/V axis (reviewed in Amiri and Stein, 2002). Based on sequence similarity to a family of vertebrate enzymes, and its localization in the Golgi apparatus, pip has been hypothesized to encode a heparansulfate 2-O-sulfotransferase (HSST). However, neither the enzymatic activity nor the substrate specificity of pip have been demonstrated directly.

Sulfation of secreted molecules occurs in the Golgi and requires the high-energy sulfate donor adenosine 3'-phosphate 5'-phosphosulfate (PAPS) to be present within that organelle. In Drosophila, PAPS is synthesized in the cytoplasm by PAPS-synthetase (Jullien et al., 1997), which incorporates both ATP-sulfurylase and Adenosine 5'-phosphosulfate-kinase (APS-kinase) activity. PAPS must be transported into the Golgi thereafter (Lyle et al., 1994) to serve as a substrate for sulfotransferases. Here, we report the first molecular identification and functional characterization of a PAPS-transporter. Mutations in this gene, which we call slalom (sll), are associated with defects in multiple signaling pathways, including Wg and Hh signaling. A phenotypic analysis suggests that the effects of sll on signal transduction are caused by its requirement for GAG modification. We present evidence that sll is also required to supply PAPS to the machinery initiating the establishment of embryonic D/V polarity, supporting the view that Pipe protein is a sulfotransferase.

November 25

Carlos Rovira: Functional genomic approach for the study of non-coding RNAs

Cells contain a variety of noncoding RNAs (ncRNA) that do not function as messenger RNA. This group includes tRNAs, rRNAs and also regulatory RNAs that influence the expression of other genes. In the last four years, it has become increasingly apparent that noncoding RNAs belonging to the last named class are impressively diverse. They have been proposed to participate in the “defense of the genome” by targeting and destroying “foreign or“ invading” nucleic acids but also in other more general mechanisms of gene regulation.

The functions described for ncRNAs thus far are extremely varied and
include: transcriptional regulation (gene silencing/chromosome
inactivation), chromosome replication, RNA processing and modification, mRNA stability and translation and even protein degradation and translocation. A common denominator for many of these processes is that apparently they are functional at early stages of embryonic development and cell differentiation.

Recent reports indicate that ncRNA are far more abundant and important than initially imagined (estimated from hundreds to thousands per genome), and therefore raised several fundamental questions:

  • How many regulatory RNAs are encoded by a genome?.
  • Given the absence in many cases of a diagnostic open reading frame,
    how can these genes be identified?
  • How can all their functions be elucidated?
  • What is the real impact of regulatory RNAs in both biology and in
    human diseases?

To answer these questions we set out to adapt or develop new techniques which would allow us to get new insights in what seems to be a fundamental question in modern biology.